title: Plasmodium falciparum malaria and Parvovirus B19; a case of acute co-infection.
abstract: BACKGROUND
  Co-infection with Plasmodium falciparum malaria and Parvovirus B19 in adults is an extremely rare occurrence and, apparently, only one case has been previously reported. Herein we describe a case of acute co-infection with severe anemia and renal failure.
  
  
  METHODS
  The patient was a 34-year-old African man presenting myalgia, fatigue, headache, anemia and hepatosplenomegaly. A thin peripheral smear showed Plasmodium falciparum trophozoites and the patient was treated with oral mefloquine. After an initial amelioration, fever, fatigue and myalgia reappeared, the anemia worsened and there was evidence of acute renal failure. No malarial parasites were found with a blood smear. A bone marrow aspiration showed marked erythroid hypoplasia. Parvovirus B19-specific IgM and IgG and viremia were positive. The patient was treated with steroids and blood cell transfusions. After ten days, anemia and renal failure progressively decreased. When last seen, the patient was asymptomatic and the blood values were within the normal range.
  
  
  CONCLUSIONS
  The diagnosis of Parvovirus B19 acute infection should be considered in any case of persistent severe anemia and/or renal failure, even in clinical conditions that are well-known causes of anemia and renal failure, such as malaria.
authors.affiliation: Institute of Infectious Diseases, University of Bari, Italy. dr_ingrassia@yahoo.it
authors.forename: F
authors.initials: F
authors.lastname: Ingrassia
authors.forename: A
authors.initials: A
authors.lastname: Gadaleta
authors.forename: P
authors.initials: P
authors.lastname: Maggi
authors.forename: G
authors.initials: G
authors.lastname: Pastore
mesh_terms: D000328:Adult; D000740:Anemia / Q000209:etiology*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000914:Antibodies, Viral / Q000097:blood; D000962:Antimalarials / Q000627:therapeutic use; D001803:Blood Transfusion; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D016778:Malaria, Falciparum / Q000150:complications* / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology; D008297:Male; D015767:Mefloquine / Q000627:therapeutic use; D010322:Parvoviridae Infections / Q000150:complications* / Q000473:pathology / Q000821:virology; D016732:Parvovirus B19, Human / Q000302:isolation & purification*; D010963:Plasmodium falciparum / Q000302:isolation & purification*; D051437:Renal Insufficiency / Q000209:etiology*; D013256:Steroids / Q000627:therapeutic use; D014766:Viremia
chemical_list: D000893:Anti-Inflammatory Agents; D000914:Antibodies, Viral; D000962:Antimalarials; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D013256:Steroids; D015767:Mefloquine